Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAMUSCULAR, INTRAVENOUSStandard

MORPHINE SULFATE

MORPHINE SULFATE

Standard Dose
2MG/ML (2MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview MORPHINE SULFATE is listed in Drugs@FDA under application 204223 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient MORPHINE SULFATE Form and strength SOLUTION;INTRAMUSCULAR, INTRAVENOUS - 2MG/ML (2MG/ML) Sponsor FRESENIUS KABI USA Submission history Latest submission status date: 2025-12-22 00:00:00.

Structured Monograph

Clinical summary

Approval overview MORPHINE SULFATE is listed in Drugs@FDA under application 204223 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient MORPHINE SULFATE Form and strength SOLUTION;INTRAMUSCULAR, INTRAVENOUS - 2MG/ML (2MG/ML) Sponsor FRESENIUS KABI USA Submission history Latest submission status date: 2025-12-22 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.